Metastasis-Directed Therapy for Oligometastatic Prostate Cancer – Prof. Bertrand Tombal, MD, PhD
Are We doing the Right Thing?
Universitaetsspital Zuerich
Diet and Prostate Cancer—Now What?
J. Kellogg Parsons, MD, MHS, FACS, reviews the Men's Eating and Living (MEAL) study, a randomized, phase III clinical trial testing diet intervention in prostate ...
Grand Rounds in Urology
ASCO 2020 prostate cancer highlights
Prof Karim Fizazi (Institut Gustave Roussy, Paris, France) chairs a virtual discussion with Prof Axel Merseburger (University Hospital Schleswig-Holstein, Lübeck, ...
ecancer
Intermediate and "High-Risk" Prostate Cancer - 2019 Prostate Cancer Patient Conference
Visit: http://www.uctv.tv/) Intermediate and High-risk Disease and multimodal therapy with Matt Cooperberg, MD; Mack Roach, MD; Eric Small, MD; James Yu, ...
University of California Television (UCTV)
Tomasz Beer, MD Speaks On Xtandi, Erleada, & Nubeqa | Excerpt from the 2019 PCRI Conference
Medical oncologist, Tomasz Beer, MD, speaks at the 2019 Prostate Cancer Patient Conference on the factors he considers when deciding to prescribe a patient ...
Prostate Cancer Research Institute
Testosterone and Prostate Cancer: Is There a Link?
Dr. Abraham Morgentaler presented "Testosterone and Prostate Cancer: Is There a Link?" at the 22nd Annual Scottsdale Prostate Cancer Symposium on Friday, ...
Grand Rounds in Urology
Oligometastatic Prostate Cancer: What is the Standard of Care?
Oligometastatic Prostate Cancer: What is the Standard of Care? by Chidi Molokwu, MBBS, FRCS (Urol), PhD, Uro-Oncology Fellow, The University of British ...
UBC Urology Rounds
Hereditary Prostate Cancer
Alexandria M. Meyer explains how prostate cancer can be an indicator for hereditary cancer susceptibility and the importance of genetic testing.
Grand Rounds in Urology
Cancer Screening & Overdiagnosis
Two basic points: 1. Not all cancers progress & 2.) Cancer survival statistics can be very misleading. [March 2018 keynote at The United States and Canadian ...
H. Gilbert Welch
Neuroendocrine Prostate Cancer (NEPC)
Dr. Jehonathan Pinthus presented "Neuroendocrine Prostate Cancer (NEPC)" at the 27th annual International Prostate Cancer Update meeting on Thursday, ...
Grand Rounds in Urology
E02.2 Prostate Cancer Predisposition: Implications for Early Detection and Treatment
Peter Nelson; Seattle, United States.
European Society of Human Genetics
Management of Advanced Hormone-sensitive and Castration-resistant Prostate Cancer
Filmed on location in Las Vegas during the 21st Annual NOCR Meeting, this webcast is part of a series that provides expert discussions from physicians and ...
ImedexCME
William Aronson, MD - Prostate Cancer Research Symposium 2015
William Aronson, MD University of California, Los Angeles, CA.
David Geffen School of Medicine UCLA
Prostate Cancer Screening
Gerald Andriole, MD, discusses the limitations and successes in the design of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) and ...
Grand Rounds in Urology
Understanding Treatment Options for Men with Localised Prostate Cancer - by Dr Kris Rasiah
Understanding Treatment Options for Men with Localised Prostate Cancer by Dr Kris Rasiah 28 April 2014.
Prostate Cancer Foundation of Australia
AACR 2011: Scientists identify KRAS rearrangements in metastatic prostate cancer
Prof Arul Chinnaiyan - University of Michigan Medical School, USA Findings published in Cancer Discovery have revealed a genetic characteristic of metastatic ...
ecancer
Systemic Therapies for the Treatment of Advanced Prostate Cancer
Visit: http://www.uctv.tv/) Rahul Aggarwal, MD and Eric Small, MD. Recorded on 06/08/2019. Series: "Prostate Cancer Patient Conference" [Professional Medical ...
University of California Television (UCTV)
EAU guidelines for treating patients with advanced prostate cancer
Dr Eleni Efstathiou (MD Anderson Cancer Center, Houston, USA) chairs a virtual discussion with Prof Álvaro Pinto (La Paz University Hospital, Madrid, Spain), ...
ecancer
2020 ASCO-GU Prostate Cancer Update | Ask a Prostate Cancer Expert
Alex asks Mark Scholz, MD, about the most exciting new developments at the 2020 American Society of Clinical Oncology's Genitourinary Cancers Symposium.
Prostate Cancer Research Institute
Keynote Presentation: Molecular Testing for Hereditary-Familial Prostate Cancer and for Risk..
Presented At: Molecular Diagnostics Virtual Eve2018 Presented By: Judd W Moul, MD, FACS - James H Semans MD Professor of Surgery, Division of Urologic ...
LabRoots
Active Surveillance vs. Watchful Waiting
PCRI's Executive Director, Mark Scholz, MD, explains the differences between two commonly confused concepts in prostate cancer nomenclature: “Watchful ...
Prostate Cancer Research Institute
2019 ASCO Annual Meeting Presscast
For more information, visit http://www.asco.org/ammrc.
ASCOcancer
The Impact of Local Treatment in Patients with Newly Diagnosed Metastatic Prostate Cancer
Dr. Piet Ost presented “The Impact of Local Treatment of the Prostate in Patients with Newly Diagnosed Metastatic Prostate Cancer” at the 6th Symposium on the ...
Grand Rounds in Urology
Selenium, Finasteride and Other Prostate Health Supplements
Please visit: http://www.mdanderson.org/prevention for more information regarding prevention and screening. Get the facts on selenium, finasteride and other ...
MD Anderson Cancer Center
Exploiting Prostate Cancer Metabolism to Prevent Disease Progression
Exploiting Prostate Cancer Metabolism to Prevent Disease Progression by Neil E. Fleshner, MD, MPH, FRCSC, Martin Barkin Professor and Chair of Urology, ...
UBC Urology Rounds
Plant-Based Diet for Your Heart | Dr. Robert Ostfeld
The position of the Medical Executive Committee of SUNY Downstate Medical Center, as recommended by the Committee and Plant-based Health and Nutrition, ...
Downstate TV
What Cancer Patients Should Know: Latest Immunotherapy News from ASCO 2018
Our panel of immunotherapy experts discusses the latest cancer immunotherapy advances featured at the world's largest oncology conference—the 2018 ...
Cancer Research Institute
Breast cancer highlights from ASCO 2019
Dr Matteo Lambertini speaks with ecancer at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about the conference highlights in breast ...
ecancer
AACR 2020 Annual Meeting Press Preview 04/23/2020
American Association for Cancer Research
Shaw Regional Cancer Center - Michael Glode, MD - Prostate Cancer Presentation
Michael Glode, MD, presents on Prostate Cancer at Shaw Regional Cancer Center in Edwards, CO.
Vail Health
Prostate Cancer: Identifying the Toothless Lions
Dr. E. David Crawford presented "Prostate Cancer: Identifying the Toothless Lions" at the 25th annual Perspectives in Urology Point Counterpoint on Sunday, ...
Grand Rounds in Urology
Dr. Dawn Lemanne - 'Carbohydrate Restriction in Cancer Therapy'
Dr. Dawn Lemanne is a Stanford-trained, board-certified integrative and medical oncologist. Dr. Lemanne has published in peer-reviewed journals and has ...
Low Carb Down Under
Clinical research in prostate cancer
Department of Medicine Grand Rounds presentation by Dr. Evan Yu, Professor, Division of Medical Oncology Department of Medicine University of Washington ...
UWDeptMedicine
Prostate Cancer and Inherited Risk - Dr Hilda High
Prostate Cancer and Inherited Risk - by Dr Hilda High 24 March 2014.
Prostate Cancer Foundation of Australia
Aggressive Treatment of Aggressive Prostate Cancer - A/Prof Henry Woo
Aggressive Treatment of Aggressive Prostate Cancer by A/Prof Henry Woo 22 September 2014.
Prostate Cancer Foundation of Australia
Blood Biomarkers in the Management of Prostate Cancer - Tarek Bismar, MD
Dr. Bismar, from the Southern Alberta Cancer Research Institute, leads a heady discussion on how innovations in examining blood and tissue-based molecular ...
PROSTAID Calgary
Prostate Cancer Initial Staging and Evaluation of Recurrent Disease with PSMA-Targeted PET
Steven Rowe, MD, PhD, gives an overview of current data on prostate-specific membrane antigen (PSMA)-targeted PET imaging for initial staging of prostate ...
Grand Rounds in Urology
Second Opinion Diagnosis in Prostate Pathology
Francisco G. La Rosa, MD, discusses how poor preparation of biopsy and prostatectomy specimens, as well as pathologists' misreadings, can lead to significant ...
Grand Rounds in Urology
Advances in Prostate Cancer Radiotherapy
Yale Cancer Center Grand Rounds | April 9, 2019 James B. Yu, MD, MHS, Associate Professor, Yale School of Medicine, Department of Therapeutic Radiology.
Yale Cancer Center
Dean Ornish, M.D. - Transform 2010 - Mayo Clinic
Dean Ornish, M.D. - Founder and President, Preventive Medicine Research Institute Reflections from over 30 years of work in preventive care, and how powerful ...
Mayo Clinic
Molecular Insights into the Germline for Prostate Cancer Initiation, Progression, and Aggressiveness
Colin C. Pritchard, MD, PhD, director of the Genetics and Solid Tumors Laboratory at the University of Washington Medical Center, discusses how germline ...
Grand Rounds in Urology
Focal Therapy, Are We Ready? - by Assoc. Prof. Phillip Stricker
Assoc. Prof. Phillip Stricker is Chairman, Department Urology at St. Vincent's Clinic, Darlinghurst and Director of St Vincent's Prostate Cancer Clinic. On 17th ...
Prostate Cancer Foundation of Australia
